|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1201 to 1300 out of 2570 for Kras

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.036s

Categories

Category: Publication
« show all
Type Details Score
Publication
25150294 | J:218707
First Author: Gough DJ
Year: 2014
Journal: Blood
Title: STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.
Volume: 124
Issue: 14
Pages: 2252-61
•
•
•
•
•
Publication
29967264 | J:265553
First Author: Makino Y
Year: 2018
Journal: Cancer Res
Title: CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.
Volume: 78
Issue: 17
Pages: 4902-4914
•
•
•
•
•
Publication
31969449 | J:285463
First Author: Vitos-Faleato J
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Requirement for epithelial p38α in KRAS-driven lung tumor progression.
Volume: 117
Issue: 5
Pages: 2588-2596
•
•
•
•
•
Publication
33782087 | J:305076
 
First Author: Kemp SB
Year: 2021
Journal: Life Sci Alliance
Title: Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages.
Volume: 4
Issue: 6
•
•
•
•
•
Publication
32579928 | J:292605
First Author: Kamata T
Year: 2020
Journal: Cell Rep
Title: Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development.
Volume: 31
Issue: 12
Pages: 107802
•
•
•
•
•
Publication
33099471 | J:309366
First Author: Kato H
Year: 2020
Journal: Cancer Genomics Proteomics
Title: Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.
Volume: 17
Issue: 6
Pages: 695-705
•
•
•
•
•
Publication
21586612 | J:174088
First Author: Corcoran RB
Year: 2011
Journal: Cancer Res
Title: STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.
Volume: 71
Issue: 14
Pages: 5020-9
•
•
•
•
•
Publication
16702406 | J:108711
First Author: Lu SL
Year: 2006
Journal: Genes Dev
Title: Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.
Volume: 20
Issue: 10
Pages: 1331-42
•
•
•
•
•
Publication
35332150 | J:322999
First Author: Yoo S
Year: 2022
Journal: Nat Commun
Title: Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.
Volume: 13
Issue: 1
Pages: 1592
•
•
•
•
•
Publication
22469842 | J:184706
First Author: Vincent DF
Year: 2012
Journal: Am J Pathol
Title: Tif1γ suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway.
Volume: 180
Issue: 6
Pages: 2214-21
•
•
•
•
•
Publication
30250643 | J:298190
First Author: De la Garza MM
Year: 2018
Journal: Oncotarget
Title: COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1α mediated tumor angiogenesis and proliferation.
Volume: 9
Issue: 68
Pages: 32972-32983
•
•
•
•
•
Publication
29526803 | J:260714
 
First Author: Qiu W
Year: 2018
Journal: Cancer Lett
Title: Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice.
Volume: 423
Pages: 71-79
•
•
•
•
•
Publication
26070712 | J:233550
First Author: Stoy C
Year: 2015
Journal: EMBO Mol Med
Title: Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy.
Volume: 7
Issue: 8
Pages: 1048-62
•
•
•
•
•
Publication
30778219 | J:282984
First Author: Nacarelli T
Year: 2019
Journal: Nat Cell Biol
Title: NAD+ metabolism governs the proinflammatory senescence-associated secretome.
Volume: 21
Issue: 3
Pages: 397-407
•
•
•
•
•
Publication
26880801 | J:231615
First Author: Rao CV
Year: 2016
Journal: Cancer Res
Title: Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer.
Volume: 76
Issue: 7
Pages: 1965-74
•
•
•
•
•
Publication
26992918 | J:287025
First Author: Drosos Y
Year: 2016
Journal: Neoplasia
Title: Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.
Volume: 18
Issue: 3
Pages: 172-84
•
•
•
•
•
Publication
31242426 | J:290870
First Author: Borghesan M
Year: 2019
Journal: Cell Rep
Title: Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3.
Volume: 27
Issue: 13
Pages: 3956-3971.e6
•
•
•
•
•
Publication
22698407 | J:189282
First Author: Pylayeva-Gupta Y
Year: 2012
Journal: Cancer Cell
Title: Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.
Volume: 21
Issue: 6
Pages: 836-47
•
•
•
•
•
Publication
23912455 | J:212614
First Author: Dutruel C
Year: 2014
Journal: Oncogene
Title: Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
Volume: 33
Issue: 26
Pages: 3401-10
•
•
•
•
•
Publication
33439550 | J:314007
First Author: Tong X
Year: 2021
Journal: EMBO Mol Med
Title: Nanog maintains stemness of Lkb1-deficient lung adenocarcinoma and prevents gastric differentiation.
Volume: 13
Issue: 3
Pages: e12627
•
•
•
•
•
Publication
26525103 | J:226758
First Author: Stromnes IM
Year: 2015
Journal: Cancer Cell
Title: T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.
Volume: 28
Issue: 5
Pages: 638-652
•
•
•
•
•
Publication
32552827 | J:309037
First Author: Gitto SB
Year: 2020
Journal: Cell Commun Signal
Title: Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells.
Volume: 18
Issue: 1
Pages: 95
•
•
•
•
•
Publication
24469043 | J:218634
First Author: Sales KU
Year: 2015
Journal: Oncogene
Title: Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis.
Volume: 34
Issue: 3
Pages: 346-56
•
•
•
•
•
Publication
29606348 | J:260702
First Author: Li L
Year: 2018
Journal: Cancer Cell
Title: GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.
Volume: 33
Issue: 4
Pages: 736-751.e5
•
•
•
•
•
Publication
25584895 | J:219808
First Author: Wong PP
Year: 2015
Journal: Cancer Cell
Title: Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
Volume: 27
Issue: 1
Pages: 123-37
•
•
•
•
•
Publication
23042302 | J:193646
First Author: Tran K
Year: 2013
Journal: Carcinogenesis
Title: The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer.
Volume: 34
Issue: 1
Pages: 199-210
•
•
•
•
•
Publication
23749641 | J:199648
First Author: Nobis M
Year: 2013
Journal: Cancer Res
Title: Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer.
Volume: 73
Issue: 15
Pages: 4674-86
•
•
•
•
•
Publication
36548516 | J:350263
First Author: Fu S
Year: 2023
Journal: Cancer Immunol Res
Title: Syntaphilin Regulates Neutrophil Migration in Cancer.
Volume: 11
Issue: 3
Pages: 278-289
•
•
•
•
•
Publication
20332237 | J:158892
First Author: Dineen SP
Year: 2010
Journal: Cancer Res
Title: Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.
Volume: 70
Issue: 7
Pages: 2852-61
•
•
•
•
•
Publication
28691927 | J:354323
First Author: Wang YT
Year: 2017
Journal: J Clin Invest
Title: Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment.
Volume: 127
Issue: 8
Pages: 2982-2997
•
•
•
•
•
Publication
30033198 | J:265912
First Author: Cong J
Year: 2018
Journal: Cell Metab
Title: Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression.
Volume: 28
Issue: 2
Pages: 243-255.e5
•
•
•
•
•
Publication
23840665 | J:203716
First Author: Courtin A
Year: 2013
Journal: PLoS One
Title: Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
Volume: 8
Issue: 6
Pages: e67330
•
•
•
•
•
Publication
36209169 | J:333480
First Author: Li J
Year: 2023
Journal: Cell Death Differ
Title: Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway.
Volume: 30
Issue: 2
Pages: 313-326
•
•
•
•
•
Publication
23407165 | J:195770
First Author: Guillaumond F
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.
Volume: 110
Issue: 10
Pages: 3919-24
•
•
•
•
•
Publication
31857853 | J:287148
First Author: Ding B
Year: 2019
Journal: Oncotarget
Title: p53-inducible SESTRINs might play opposite roles in the regulation of early and late stages of lung carcinogenesis.
Volume: 10
Issue: 65
Pages: 6997-7009
•
•
•
•
•
Publication
28254412 | J:240391
 
First Author: Leal AS
Year: 2017
Journal: Cancer Lett
Title: Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer.
Volume: 394
Pages: 76-87
•
•
•
•
•
Publication
27300433 | J:232330
First Author: DuFort CC
Year: 2016
Journal: Cancer Cell
Title: Tension and Transformation in Pancreas Cancer: Can Phenotype Break Free from the Chrysalis of Genotype?
Volume: 29
Issue: 6
Pages: 780-782
•
•
•
•
•
Publication
37190324 | J:335631
 
First Author: Yang D
Year: 2023
Journal: Cancers (Basel)
Title: Cross-Dataset Single-Cell Analysis Identifies Temporal Alterations in Cell Populations of Primary Pancreatic Tumor and Liver Metastasis.
Volume: 15
Issue: 8
•
•
•
•
•
Publication
30930235 | J:274212
 
First Author: Fabian A
Year: 2019
Journal: Cancer Lett
Title: Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.
Volume: 453
Pages: 95-106
•
•
•
•
•
Publication
25675507 | J:220173
First Author: Guillaumond F
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.
Volume: 112
Issue: 8
Pages: 2473-8
•
•
•
•
•
Publication
28315323 | J:325940
First Author: Jiang SH
Year: 2017
Journal: Gastroenterology
Title: Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Volume: 153
Issue: 1
Pages: 277-291.e19
•
•
•
•
•
Publication
28408354 | J:242491
 
First Author: Chen X
Year: 2017
Journal: Cancer Lett
Title: Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
Volume: 399
Pages: 20-28
•
•
•
•
•
Publication
30401713 | J:270055
First Author: Elahi-Gedwillo KY
Year: 2019
Journal: Cancer Res
Title: Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.
Volume: 79
Issue: 2
Pages: 372-386
•
•
•
•
•
Publication
26722025 | J:309202
First Author: Liao J
Year: 2016
Journal: Anticancer Res
Title: Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
Volume: 36
Issue: 1
Pages: 27-37
•
•
•
•
•
Publication
29621546 | J:271449
First Author: Cao XY
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Volume: 499
Issue: 3
Pages: 584-593
•
•
•
•
•
Publication
35752173 | J:354665
First Author: He D
Year: 2022
Journal: Mol Cell
Title: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis.
Volume: 82
Issue: 16
Pages: 3045-3060.e11
•
•
•
•
•
Publication
25368022 | J:218262
First Author: Sainz B Jr
Year: 2014
Journal: Cancer Res
Title: ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
Volume: 74
Issue: 24
Pages: 7309-20
•
•
•
•
•
Publication
23475959 | J:212220
First Author: Soucek L
Year: 2013
Journal: Genes Dev
Title: Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.
Volume: 27
Issue: 5
Pages: 504-13
•
•
•
•
•
Publication
19460966 | J:149213
First Author: Olive KP
Year: 2009
Journal: Science
Title: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Volume: 324
Issue: 5933
Pages: 1457-61
•
•
•
•
•
Publication
18716624 | J:141029
First Author: Soucek L
Year: 2008
Journal: Nature
Title: Modelling Myc inhibition as a cancer therapy.
Volume: 455
Issue: 7213
Pages: 679-83
•
•
•
•
•
Publication
21403843 | J:171634
First Author: Fendrich V
Year: 2011
Journal: Neoplasia
Title: Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Volume: 13
Issue: 2
Pages: 180-6
•
•
•
•
•
Publication
36919330 | J:335589
First Author: He F
Year: 2023
Journal: Cancer Res
Title: FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner.
Volume: 83
Issue: 10
Pages: 1628-1645
•
•
•
•
•
Publication
26144316 | J:224529
First Author: Palm W
Year: 2015
Journal: Cell
Title: The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.
Volume: 162
Issue: 2
Pages: 259-270
•
•
•
•
•
Publication
28757253 | J:252097
First Author: Roe JS
Year: 2017
Journal: Cell
Title: Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
Volume: 170
Issue: 5
Pages: 875-888.e20
•
•
•
•
•
Publication
38872370 | J:350483
First Author: Yamaguchi J
Year: 2024
Journal: Cancer Med
Title: Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer.
Volume: 13
Issue: 11
Pages: e7395
•
•
•
•
•
Publication
35561453 | J:325347
 
First Author: Jiang SH
Year: 2022
Journal: EBioMedicine
Title: Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer.
Volume: 80
Pages: 104050
•
•
•
•
•
Publication
19118015 | J:143028
First Author: Menon R
Year: 2009
Journal: Cancer Res
Title: Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer.
Volume: 69
Issue: 1
Pages: 300-9
•
•
•
•
•
Publication
28453537 | J:245950
First Author: Kersemans V
Year: 2017
Journal: PLoS One
Title: An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.
Volume: 12
Issue: 4
Pages: e0176693
•
•
•
•
•
Publication
29135982 | J:252226
First Author: Baird JR
Year: 2017
Journal: PLoS One
Title: STING expression and response to treatment with STING ligands in premalignant and malignant disease.
Volume: 12
Issue: 11
Pages: e0187532
•
•
•
•
•
Publication
36271032 | J:331742
First Author: Lakshmanan I
Year: 2022
Journal: Oncogene
Title: Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
Volume: 41
Issue: 48
Pages: 5147-5159
•
•
•
•
•
Publication
24713432 | J:212458
First Author: Davies CC
Year: 2014
Journal: Cancer Res
Title: Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma.
Volume: 74
Issue: 12
Pages: 3344-56
•
•
•
•
•
Publication
23963802 | J:303013
First Author: Husain K
Year: 2013
Journal: Cancer Prev Res (Phila)
Title: Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
Volume: 6
Issue: 10
Pages: 1074-83
•
•
•
•
•
Publication
35212370 | J:325481
First Author: Schniers BK
Year: 2022
Journal: Biochem J
Title: Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer.
Volume: 479
Issue: 5
Pages: 719-730
•
•
•
•
•
Publication
27216178 | J:232779
First Author: Schultz MJ
Year: 2016
Journal: Cancer Res
Title: The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
Volume: 76
Issue: 13
Pages: 3978-88
•
•
•
•
•
Publication
26359451 | J:226787
First Author: Dosch JS
Year: 2015
Journal: Cancer Res
Title: Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.
Volume: 75
Issue: 21
Pages: 4582-92
•
•
•
•
•
Publication
32903551 | J:308873
 
First Author: Zhang Z
Year: 2020
Journal: Front Immunol
Title: Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime.
Volume: 11
Pages: 1996
•
•
•
•
•
Publication
37267953 | J:338213
First Author: Haston S
Year: 2023
Journal: Cancer Cell
Title: Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer.
Volume: 41
Issue: 7
Pages: 1242-1260.e6
•
•
•
•
•
Publication
30863319 | J:309716
 
First Author: Li C
Year: 2019
Journal: Front Physiol
Title: MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
Volume: 10
Pages: 147
•
•
•
•
•
Publication
38902362 | J:352006
First Author: Jacobson R
Year: 2024
Journal: Sci Rep
Title: Differential extracellular vesicle concentration and their biomarker expression of integrin α(v)/β(5), EpCAM, and glypican-1 in pancreatic cancer models.
Volume: 14
Issue: 1
Pages: 14273
•
•
•
•
•
Publication
37255660 | J:347476
First Author: Kaune T
Year: 2023
Journal: iScience
Title: Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer.
Volume: 26
Issue: 6
Pages: 106841
•
•
•
•
•
Publication
29050937 | J:253991
First Author: Jiang S
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
Volume: 494
Issue: 1-2
Pages: 113-119
•
•
•
•
•
Publication
23911236 | J:202526
First Author: Patra KC
Year: 2013
Journal: Cancer Cell
Title: Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Volume: 24
Issue: 2
Pages: 213-228
•
•
•
•
•
Publication
29414775 | J:262781
First Author: Maity G
Year: 2018
Journal: J Biol Chem
Title: The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Volume: 293
Issue: 12
Pages: 4334-4349
•
•
•
•
•
Publication
33603164 | J:303964
First Author: Solan JL
Year: 2021
Journal: Oncogene
Title: Cx43 phosphorylation sites regulate pancreatic cancer metastasis.
Volume: 40
Issue: 10
Pages: 1909-1920
•
•
•
•
•
Publication
29567829 | J:260710
First Author: Pushalkar S
Year: 2018
Journal: Cancer Discov
Title: The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.
Volume: 8
Issue: 4
Pages: 403-416
•
•
•
•
•
Publication
19477428 | J:149663
First Author: Singh A
Year: 2009
Journal: Cancer Cell
Title: A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.
Volume: 15
Issue: 6
Pages: 489-500
•
•
•
•
•
Publication
22220202 | J:182325
First Author: Colvin EK
Year: 2011
Journal: PLoS One
Title: Retinoid signaling in pancreatic cancer, injury and regeneration.
Volume: 6
Issue: 12
Pages: e29075
•
•
•
•
•
Publication
21673986 | J:174139
First Author: Wang Z
Year: 2011
Journal: PLoS One
Title: Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.
Volume: 6
Issue: 6
Pages: e20537
•
•
•
•
•
Publication
33110235 | J:301792
First Author: Nimmakayala RK
Year: 2021
Journal: Oncogene
Title: Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Volume: 40
Issue: 1
Pages: 215-231
•
•
•
•
•
Publication
26310823 | J:224975
 
First Author: Schneider P
Year: 2015
Journal: Nat Commun
Title: Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
Volume: 6
Pages: 8023
•
•
•
•
•
Publication
22606359 | J:220921
First Author: Wang Z
Year: 2012
Journal: PLoS One
Title: Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.
Volume: 7
Issue: 5
Pages: e37308
•
•
•
•
•
Publication
27061193 | J:241175
First Author: Carapuça EF
Year: 2016
Journal: J Pathol
Title: Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma.
Volume: 239
Issue: 3
Pages: 286-96
•
•
•
•
•
Publication
29222037 | J:253809
 
First Author: Rahn S
Year: 2018
Journal: Cancer Lett
Title: Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.
Volume: 415
Pages: 129-150
•
•
•
•
•
Publication
30827862 | J:275674
First Author: Halbrook CJ
Year: 2019
Journal: Cell Metab
Title: Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer.
Volume: 29
Issue: 6
Pages: 1390-1399.e6
•
•
•
•
•
Publication
33878394 | J:306548
 
First Author: Chaudhary S
Year: 2021
Journal: Cancer Lett
Title: Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring.
Volume: 510
Pages: 79-92
•
•
•
•
•
Publication
24229708 | J:206737
First Author: Lee YS
Year: 2013
Journal: Cancer Cell
Title: Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
Volume: 24
Issue: 5
Pages: 603-16
•
•
•
•
•
Publication
22351932 | J:182504
First Author: Cook N
Year: 2012
Journal: J Exp Med
Title: Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma.
Volume: 209
Issue: 3
Pages: 437-44
•
•
•
•
•
Publication
35626052 | J:349029
 
First Author: Natarajan V
Year: 2022
Journal: Cancers (Basel)
Title: Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Adenocarcinoma.
Volume: 14
Issue: 10
•
•
•
•
•
Publication
33792183 | J:349047
First Author: Lakshmanan I
Year: 2021
Journal: Mol Oncol
Title: ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation.
Volume: 15
Issue: 7
Pages: 1866-1881
•
•
•
•
•
Publication
31815046 | J:349040
First Author: Yang J
Year: 2019
Journal: Am J Cancer Res
Title: Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Volume: 9
Issue: 11
Pages: 2456-2468
•
•
•
•
•
Publication
23836645 | J:198792
First Author: Neesse A
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.
Volume: 110
Issue: 30
Pages: 12325-30
•
•
•
•
•
Publication
31369062 | J:290838
First Author: Mendez R
Year: 2020
Journal: Carcinogenesis
Title: Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Volume: 41
Issue: 5
Pages: 561-570
•
•
•
•
•
Publication
21726810 | J:174374
First Author: Oliver TG
Year: 2011
Journal: Mol Cell
Title: Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop.
Volume: 43
Issue: 1
Pages: 57-71
•
•
•
•
•
Publication
20303350 | J:349071
First Author: Morton JP
Year: 2010
Journal: Gastroenterology
Title: Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.
Volume: 139
Issue: 1
Pages: 292-303
•
•
•
•
•
Publication
30061636 | J:267421
First Author: Ferro R
Year: 2018
Journal: Oncogene
Title: GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.
Volume: 37
Issue: 49
Pages: 6368-6382
•
•
•
•
•
Publication
27248578 | J:349079
 
First Author: Lee JW
Year: 2016
Journal: Curr Protoc Pharmacol
Title: Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.
Volume: 73
Pages: 14.39.1-14.39.20
•
•
•
•
•
Publication
29361972 | J:257067
First Author: Popis MC
Year: 2018
Journal: BMC Res Notes
Title: Considerations for skin carcinogenesis experiments using inducible transgenic mouse models.
Volume: 11
Issue: 1
Pages: 67
•
•
•
•
•
Publication
32251410 | J:349151
First Author: Ferguson FM
Year: 2020
Journal: Nat Chem Biol
Title: Discovery of a selective inhibitor of doublecortin like kinase 1.
Volume: 16
Issue: 6
Pages: 635-643
•
•
•
•
•
Publication
31433988 | J:299226
First Author: Burrack AL
Year: 2019
Journal: Cell Rep
Title: Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.
Volume: 28
Issue: 8
Pages: 2140-2155.e6
•
•
•
•
•
Publication
36861840 | J:349139
First Author: Rodríguez-Merced NJ
Year: 2023
Journal: STAR Protoc
Title: Protocol to culture and image pancreatic ductal adenocarcinoma tumor slices to study T cell migration.
Volume: 4
Issue: 1
Pages: 102135
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom